Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Europe Urinary Drainage Bags Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Europe Urinary Drainage Bags Market Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Europe Urinary Drainage Bags Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Europe Urinary Drainage Bags Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Leg Bags
      2. Large Capacity Bags

• 8.   Europe Urinary Drainage Bags Market, By Capacity Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. 0-500 ml
      2. 500-1000 ml
      3. 1000-2000 ml
      4. More than 2000 ml

• 9.   Europe Urinary Drainage Bags Market, By Number of Chambers Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Single Chamber
      2. 2-chambers
      3. 3-chambers

• 10.   Europe Urinary Drainage Bags Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Hospitals
      2. Clinics
      3. Ambulatory Surgical Centers
      3. Home Care
      4. Others

• 11.  Europe Urinary Drainage Bags Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 12.   Market Share Analysis and Competitive Landscape
  •   1. Europe Landscape - Key Players, Revenue and Presence
      2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Europe Emerging Companies
      4. Europe - Market Share Analysis and Key Regional Players
      5. Europe Key Player - Growth Matrix
    
• 13.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •   1. Coloplast A/S
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. ConvaTec Group PLC
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Cardinal Health
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. BD (Becton, Dickinson, and Company)
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. Braun Melsungen AG
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Clinisupplies Ltd. (Healthium Medtech)
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Hollister Incorporated
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Flexicare Medical Limited
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. Teleflex Incorporated
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. MANFRED SAUER GMBH
       10.1.Company Overview
       10.2.Product Portfolio
       10.3.SWOT Analysis
       10.4.Financial Overview
       10.5.Strategic Overview

• 14.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                 administrations
      5. The overall economic slowdown of the developing and developed nations

• 15.   FutureWise SME Key Takeaway Points for Client